Latest News

Three consumer dividend stocks that have held up in past downturns face a tough test -- here's what to look for in November.

A TFSA can pay Canadians roughly $350 a month tax free. Learn how Enbridge and Royal Bank dividends could build that income, and the rules that protect it.

Amid a tech sell-off, NXP Semiconductors, Amphenol and F5 announced major buyback programs, with NXP adding $5 billion, Amphenol unveiling a $4 billion plan and F5 boosting capacity to $1.8 billion.

Amazon's big bet on X-Energy could give this nuclear IPO stock a crucial advantage over rival Oklo.

Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration granted accelerated approval to VOCERYQ, formerly known as INO-3107, as a nonsurgical treatment intended to reduce the frequency of surgeries in adults with recurrent respiratory papillomatosis, or RRP. VOCERYQ is the co

TAT Technologies (NASDAQ:TATT) reported record third-quarter 2026 revenue and adjusted EBITDA, as demand in its auxiliary power unit, or APU, business, heat exchangers and trading, leasing and distribution operations supported growth and margin expansion. Revenue increased 20.2% year over year to $

Marriott International (NASDAQ:MAR) reported third-quarter results that exceeded its prior expectations, supported by broad-based travel demand, higher room rates and continued development activity. The company raised its full-year global RevPAR outlook and said it expects demand trends to remain st

FOX (NASDAQ:FOX) reported record first-quarter fiscal 2027 revenue and EBITDA, supported by its FIFA Men’s World Cup coverage, political advertising, distribution gains and continued growth at streaming service Tubi. Revenue rose 22% from the prior-year period to $4.6 billion, while EBITDA increase

Another rate hike will all but solidify the establishment of a new, hawkish economic environment investors will want to respond to appropriately.

Inflation is heading toward 3.5% in Canada. See how two TSX stocks, CN Rail and Enbridge, pass on higher costs, keep customers and protect their dividends.

AeroVironment lost a massive federal contract earlier this year, and the stock plunged. Is the beaten-down stock worth buying?

Reddit shares plunged on weak user growth.

Strategy posted a $19.5 billion Q3 net income from unrealized Bitcoin gains, but is pausing BTC buys and stock sales to repurchase high-yield preferred shares and shore up its balance sheet.

Wall Street expects Sandisk stock to surge over the coming year, but it could outpace expectations.

The company's shares beat the index all six times. Can investors count on a seventh?

Centrus Energy's recent acquisition boosts its nuclear supply chain and diversifies earnings.

Stéphane Bancel has high hopes for the company's cancer vaccine, beyond just treating melanoma.

The market may be wrong about Alphabet’s prospects.

The bitcoin price tries to rebound following last week's $6.3 billion theft from Binance. Morgan Stanley hit Coinbase stock with a downgrade.

Patient investors should reap the rewards from holding the stock.

Banks are high‑quality businesses, but after a strong run-up over the last few years, investors should re-balance and maintain portfolio diversification.

The FDA said Monday it will make an approval decision on Uniqure's Huntington's gene therapy by May 1. But Uniqure stock fell.

The market for GLP-1 drugs is forecast to explode. It may be understated still.

These are tough times for defense stocks, but GE Aerospace and RTX may look good relative to the group six months after Election Day.

Cameco missed Q3 2026 earnings and revenue estimates as production fell and costs rose, with contract ceilings and buy-ins preventing the uranium miner from fully capturing soaring spot prices.